BackLemaitre Vascular Overview

Lemaitre Vascular Total Current Liabilities

Track Lemaitre Vascular's total current liabilities ($30M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$29.93M
↓ 2.86% YoYΔ $-881000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Lemaitre Vascular Total Current Liabilities History

Loading

Lemaitre Vascular vs. peers: Total Current Liabilities Comparison

Loading

Lemaitre Vascular Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Lemaitre Vascular (LMAT) FAQ

The latest total current liabilities for LMAT is $30M as of June 2026. That compares with $31M in the prior-year period — down 2.9% year over year. Investors often review this figure alongside Lemaitre Vascular's historical trend and sector peers before judging valuation or financial health.

Over the past year, LMAT's total current liabilities moved from $31M to $30M — a 2.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lemaitre Vascular's operating scale or balance-sheet position.

A total current liabilities figure of $30M for LMAT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LMAT's total current liabilities ($30M), review year-over-year change from $31M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Lemaitre Vascular's total current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.